Published in Heart on December 01, 2005
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med (2003) 9.00
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet (2002) 8.09
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. Eur Heart J (2003) 6.71
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (2004) 5.94
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med (2002) 4.25
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med (2001) 3.85
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med (1999) 3.81
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Characterizing vulnerable plaque features with intravascular elastography. Circulation (2003) 2.07
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol (2004) 1.84
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol (1992) 1.82
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest (1991) 1.66
Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial. Catheter Cardiovasc Interv (2003) 1.64
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation (1998) 1.63
Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Eur Heart J (2003) 1.58
Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation (2000) 1.49
Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol (2001) 1.43
Stem cells and repair of the heart. Lancet (2004) 1.25
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol (2004) 1.14
Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2004) 1.08
Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circ J (2004) 0.95
Management of microvascular dysfunction and reperfusion injury. Heart (2005) 0.91
Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography. Am Heart J (2004) 0.91
Simulation of particle-hemodynamics in a partially occluded artery segment with implications to the initiation of microemboli and secondary stenoses. J Biomech Eng (1998) 0.85
Plaque sealing by coronary angioplasty. Heart (2004) 0.79
Coronary plaque morphology and frequency of ulceration distant from culprit lesions in patients with unstable and stable presentation. Arterioscler Thromb Vasc Biol (2003) 0.79
Identification of "vulnerable plaque" using virtual histology in angiographically benign looking lesion of proximal left anterior descending artery. Cardiovasc Radiat Med (2004) 0.77
Facilitated percutaneous coronary intervention. Heart (2005) 0.77
Resuscitation of asphyxiated newborns with room air or 100% oxygen at birth: a multicentric clinical trial. Indian Pediatr (2003) 3.56
Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol (2002) 3.36
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Effect of immunosuppression on dengue virus infection in mice. J Gen Virol (1977) 2.46
A prospective, longitudinal diffusion tensor imaging study of brain injury in newborns. Neurology (2002) 2.23
Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res (1997) 2.09
Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J (1992) 1.98
The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci U S A (2000) 1.96
Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). J Med Chem (2002) 1.94
Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res (1997) 1.86
Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone (1997) 1.84
Host defence mechanisms against dengue virus infection of mice. J Gen Virol (1978) 1.83
Production of cytotoxic factor in the spleen of dengue virus-infected mice. Immunology (1980) 1.73
Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology (1999) 1.71
Control of in vitro and in vivo spread of coxsackievirus B4 infection by sensitized spleen cells and antibody. J Infect Dis (1978) 1.62
Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology (1995) 1.61
Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. J Am Coll Cardiol (1991) 1.58
Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. J Am Coll Cardiol (1990) 1.56
Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol (1983) 1.54
Osteoporosis: association of recent fractures with quantitative US findings. Radiology (1996) 1.50
Dengue virus-induced thymus-derived suppressor cells in the spleen of mice. Immunology (1979) 1.50
Virological investigations of acute encephalopathy in India. Arch Dis Child (1990) 1.49
Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol (1998) 1.49
Persistence, latency and reactivation of Japanese encephalitis virus infection in mice. J Gen Virol (1986) 1.48
Diabetic autonomic neuropathy causing gall bladder dysfunction. J Assoc Physicians India (2000) 1.46
Carotid artery stents: early and intermediate follow-up with Doppler US. Radiology (1997) 1.45
Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol (1991) 1.44
Homograft mitral valve replacement: five years' results. J Thorac Cardiovasc Surg (2000) 1.40
Intracoronary stenting using slotted tubular stents with intravascular ultrasound and anticoagulation. Cathet Cardiovasc Diagn (1996) 1.39
Tricuspid balloon valvuloplasty: can the balloon be floated into the right ventricle? Cathet Cardiovasc Diagn (1996) 1.39
Characterization of the cytotoxic factor produced in the spleen of dengue virus-infected mice. Immunology (1980) 1.36
A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health (1999) 1.35
Effect of dengue virus infection on Fc-receptor functions of mouse macrophages. J Gen Virol (1983) 1.33
Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology (1998) 1.33
Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology (1996) 1.33
Japanese encephalitis epidemic in Uttar Pradesh, India during 1978. Indian J Med Res (1982) 1.32
Classification of osteoporosis based on bone mineral densities. J Bone Miner Res (2001) 1.31
Living environment and schooling of children with HIV-infected parents in southwest China. AIDS Care (2006) 1.29
Role of macrophages in the transmission of dengue virus-induced suppressor signal to a subpopulation of T lymphocytes. Ann Immunol (Paris) (1982) 1.26
Variable effect on peripheral blood leucocytes during JE virus infection of man. Clin Exp Immunol (1979) 1.21
Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res (1992) 1.19
Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency (1994) 1.19
Radiological and neurophysiological changes in Japanese encephalitis. J Neurol Neurosurg Psychiatry (1994) 1.19
Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol (1991) 1.17
Plasma fluorination of carbon-based materials for imprint and molding lithographic applications. Appl Phys Lett (2008) 1.17
Increased capillary permeability mediated by a dengue virus-induced lymphokine. Immunology (1990) 1.17
Cytotoxicity of filtrates of haemolytic Escherichia coli. J Med Microbiol (1969) 1.17
Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2000) 1.15
Depressed macrophage functions in dengue virus-infected mice: role of the cytotoxic factor. Br J Exp Pathol (1982) 1.12
Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynaecol Obstet (2005) 1.12
Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus. Immunology (1984) 1.11
Assessment of left ventricular performance during percutaneous transluminal coronary angioplasty: a study by intravenous digital subtraction ventriculography. Br Heart J (1988) 1.11
Perceived sources of stress amongst Indian dental students. Eur J Dent Educ (2009) 1.10
Thymus-dependent lymphocytes of dengue virus-infected mice spleens mediate suppression through prostaglandin. Immunology (1981) 1.10
Differential depletion of T lymphocytes in the spleen of dengue virus-infected mice. Immunology (1979) 1.10
Inhibition of E-rosette formation and phagocytosis by human blood leucocytes after treatment with the dengue virus-induced cytotoxic factor. Immunology (1982) 1.10
Induction of suppressor cells in Japanese encephalitis virus infected mice. Br J Exp Pathol (1983) 1.09
Detection of local and systemic cytokines in adult periodontitis. J Periodontol (1996) 1.08
Virological study of an epidemic of febrile illness with haemorrhagic manifestations at Kanpur, India, during 1968. Bull World Health Organ (1970) 1.07
Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res (1990) 1.07
Characterization of the cytotoxin produced by macrophages in response to dengue virus-induced cytotoxic factor. Br J Exp Pathol (1983) 1.06
Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J Infect Dis (1978) 1.04
Effects of age on dopamine transporters in healthy humans. J Nucl Med (1999) 1.04
Japanese encephalitis--an important cause of acute childhood encephalopathy in Lucknow, India. Postgrad Med J (1988) 1.04
Who pays for biliary complications following liver transplant? A business case for quality improvement. Am J Transplant (2006) 1.03
A comparative study of trabecular bone properties in the spine and femur using high resolution MRI and CT. J Bone Miner Res (1998) 1.03
Transplacental infection with Japanese encephalitis virus. J Infect Dis (1980) 1.03
Primary tubercular liver abscess rupture leading to parietal wall abscess: a rare disease with a rare complication. J Postgrad Med (2011) 1.02
Congenital infection of mice with Japanese encephalitis virus. Infect Immun (1981) 1.02
Dengue virus-induced helper T cells. Indian J Med Res (1987) 1.01
Experimental evaluation of antipyretic and analgesic activity of aspartame. Indian J Pharmacol (2011) 1.01
Clinical sequelae of Japanese encephalitis in children. Indian J Med Res (1993) 1.00
Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure. Br Med J (1980) 1.00
Macrophage functions during dengue virus infection: antigenic stimulation of B cells. Immunology (1987) 0.99
Suitability of the Cordis Stabilizer marker guide wire for quantitative coronary angiography calibration: an in vitro and in vivo study. Catheter Cardiovasc Interv (2001) 0.99
Japanese encephalitis virus latency following congenital infection in mice. J Gen Virol (1986) 0.99
The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart (1997) 0.99
Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy. Neurology (2012) 0.99
Effect of dengue virus-induced cytotoxin on capillary permeability. J Exp Pathol (Oxford) (1990) 0.99
Coronary hemodynamics during percutaneous transluminal coronary angioplasty. Am J Cardiol (1982) 0.98
Extracranial vertebral artery stent placement: in-hospital and follow-up results. J Neurosurg (1999) 0.98
Obligatory role of macrophages in dengue virus antigen presentation to B lymphocytes. Immunology (1989) 0.98
Magnetic resonance imaging of trabecular bone structure in the distal radius: relationship with X-ray tomographic microscopy and biomechanics. Osteoporos Int (1996) 0.97
Variable effects of dengue virus-induced cytotoxic factors on different subpopulations of macrophages. Immunology (1987) 0.97
Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: short-term precision in vivo and comparison to dual X-ray absorptiometry. J Bone Miner Res (1995) 0.96
A retrospective study of etiopathological and preventive factors in a burns unit in Saudi Arabia. Burns (1997) 0.96
Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J Med Microbiol (2000) 0.96
Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci (1993) 0.96
Cell spreading as a hydrodynamic process. Soft Matter (2010) 0.95
Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages. Clin Exp Immunol (1991) 0.95
A study of prevalence and risk factors of senile cataract in rural areas of western U.P. Indian J Ophthalmol (1986) 0.95
Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa. J Biol Chem (2001) 0.94
Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding. J Biol Chem (2000) 0.94
Magnetic resonance imaging features of submitral left ventricular aneurysm. Indian Heart J (1998) 0.93
Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood (1999) 0.92
Target lymphoid cells for the cytotoxic factor produced in the spleen of dengue virus-infected mice. Immunol Lett (1981) 0.92
Inhibition of production of dengue virus induced cytotoxic factor by treatment with cycloheximide & mitomycin C. Indian J Exp Biol (1982) 0.92
Effect of dengue virus-induced macrophage cytotoxin on functions of human blood leucocytes. Indian J Med Res (1984) 0.92
Degradation of Japanese encephalitis virus by neutrophils. Int J Exp Pathol (1999) 0.91